Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. / Plumpton, Catrin; Yip, Vincent L. M. ; Alfirevic, Ana et al.
Yn: Epilepsia, 04.2015.
Yn: Epilepsia, 04.2015.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Plumpton, C, Yip, VLM, Alfirevic, A, Marson, AG, Pirmohamed, M & Hughes, D 2015, 'Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy', Epilepsia. https://doi.org/10.1111/epi.12937
APA
Plumpton, C., Yip, V. L. M., Alfirevic, A., Marson, A. G., Pirmohamed, M., & Hughes, D. (2015). Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. Epilepsia. https://doi.org/10.1111/epi.12937
CBE
Plumpton C, Yip VLM, Alfirevic A, Marson AG, Pirmohamed M, Hughes D. 2015. Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. Epilepsia. https://doi.org/10.1111/epi.12937
MLA
Plumpton, Catrin et al. "Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy". Epilepsia. 2015. https://doi.org/10.1111/epi.12937
VancouverVancouver
Plumpton C, Yip VLM, Alfirevic A, Marson AG, Pirmohamed M, Hughes D. Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. Epilepsia. 2015 Ebr. Epub 2015 Chw 26. doi: 10.1111/epi.12937
Author
RIS
TY - JOUR
T1 - Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy
AU - Plumpton, Catrin
AU - Yip, Vincent L. M.
AU - Alfirevic, Ana
AU - Marson, Anthony G.
AU - Pirmohamed, Munir
AU - Hughes, Dyfrig
PY - 2015/4
Y1 - 2015/4
U2 - 10.1111/epi.12937
DO - 10.1111/epi.12937
M3 - Article
JO - Epilepsia
JF - Epilepsia
SN - 1528-1167
ER -